Pulmonary Hypertension Research

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer
Causes of PH
Ineffective Therapies


Active research for pulmonary hypertension is largely focusing on causes, antibodies, and treatments. (Also see Pulmonary Hypertension Overview, Scleroderma Lung Involvement, What is Scleroderma?, Types of Scleroderma, and Systemic Sclerosis)

Recent advances in scleroderma-associated (SSc) - pulmonary hypertension. Although there have been many recent advances in SSc-pulmonary hypertension, further research is needed in order to prevent/cure this deadly complication. PubMed, Curr Opin Rheumatol, 2014 Nov;26(6):637-45.

Combined Pulmonary Fibrosis and Emphysema (CPFE) Among Patients With Scleroderma (SSc)-Associated Pulmonary Hypertension (PH). There appears to be no difference in the severity of PH or in pulmonary function between SSc-PH patients with and without CPFE. Chest, 2013;144. (Also see Pulmonary Fibrosis)

New study will explore impact of exercise on pulmonary hypertension (PAH). The objective of this study will be finding identifiers that separate PAH patients who will benefit from exercise from those whose condition will worsen from it. University of Wisconsin-Madison News. 08/26/2011.


Interferon and alternative activation of macrophage/monocytes in systemic sclerosis-associated pulmonary arterial hypertension. This study explores the relationship between biomarkers of pulmonary arterial hypertension (PAH), interferon-regulated gene expression and alternatively activated macrophages (AAM) in systemic sclerosis (SSc). Romy B. Christmann MD, PhD, Arthritis and Rheumatism, 18 MAR 2011.


What Causes Pulmonary Hypertension? Certain factors appear to increase your chances of developing pulmonary arterial hypertension (PAH). National Heart, Blood and Lung Institute.

T-Helper 17 Cell Polarization in Pulmonary Arterial Hypertension. T helper 17 cell immune polarization in patients with PAH has been highlighted, as has been previously demonstrated in other chronic inflammatory and autoimmune conditions. Chest, 2015;147(6):1610-1620.

Significance of serum uric acid (UA) in pulmonary hypertension (PH) due to systemic sclerosis: a pilot study. Among patients with PH, UA values were inversely correlated with the SMWT (6-minute walk test) distance. Serum UA values increased in proportion to the functional capacity in PH patients with scleroderma.T Dimitroulas. (PubMed) Rheumatol Int, 2010 Jul 25.

Ineffective Therapies

Calcium channel blockers do not protect scleroderma patients from developing pulmonary hypertension

Immunosuppressives do not prevent pulmonary hypertension in scleroderma patients.

Prevalence of PH/PAH in Scleroderma (Systemic Sclerosis, SSc)

Prevalence of pulmonary arterial hypertension (PAH) in patients with connective tissue diseases: a systematic review of the literature. Prevalence of PAH in patients with connective tissue diseases was substantially higher than that of idiopathic PAH based on pooled prevalence estimates. PubMed, Clin Rheumatol, 2013 Jun 20. (Also see Connective Tissue Disease)

"PAH in SSc occurs in a significant proportion of (systemic scleroderma) patients without any "red flag signs" in early stages." Journal of Association of Physicians of India.

Go to Secondary Pulmonary Hypertension
Most Recent Donors

Winn Schillberg
Reading Voices of Scleroderma Books: Diana Kramer.
Sharing Scleroderma Awareness Bracelets: Deb Martin, Brenda Miller, Vickie Risner.
Thanks to UNITED WAY donors of Central New Mexico and Snohomish County!

In Loving Memory

Patricia Ann Black: Marilyn Currier, Shelley Ensz, Richard Howitt, Gerald and Pat Ivanejko, Juno Beach Condo Association, Keith and Rosalyn Miller, and Elaine Wible.
Gayle Hedlin: Daniel and Joann Pepper and Nancy Smithberg.
Janet Paulmenn: Anonymous, Mary Jo Austin, Shelley Blaser, Susan Book, Dennis and Pat Clayton, Grace Cunha, Cindy Dorio, Michael and Patricia Donahue, Shelley Ensz, Nancy Falkenhagen, Jo Frowde, Alice Gigl, Margaret Hollywood, Karen Khalaf and Family, Susan Kvarantan, Bradley Lawrence, Jillyan Little, Donna Madge, Michele Maxson, Barry and Judith McCabe, John Moffett, My Tribute Foundation, Joan-Marie Permison, John Roberts, Margaret Roof, Maryellen Ryan, Mayalin and Kiralee Murphy, Nancy Settle-Murphy, and Bruce and Elizabeth Winter.


SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA

Email [email protected] to request our Welcome email, or to report bad links or to update this page content.

TOLL FREE HOTLINE 800-564-7099
Free to U.S. and Canadian Callers. Ask for our Free Info Packet by mail or email!
Scleroderma, Pulmonary Arterial Hypertension, and related illnesses.
Privacy Policy.

The most important thing in the world to know about scleroderma is!
Donate Now
Copyright 1998-2016, International Scleroderma Network. AKA Scleroderma from A to Z and SCLERO.ORG. All Rights Reserved.